Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma
- 1 June 2018
- journal article
- research article
- Published by Elsevier in The Surgeon
- Vol. 16 (3) , 163-170
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Comparison of Hepatic Resection and Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Meta-Analysis of 16,103 PatientsScientific Reports, 2014
- Why does living donor liver transplantation flourish in Asia?Nature Reviews Gastroenterology & Hepatology, 2013
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinomaJournal of Hepatology, 2013
- Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide surveyJournal of Hepatology, 2013
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2012
- Hepatocellular carcinomaThe Lancet, 2012
- A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular CarcinomaAnnals of Surgery, 2006
- Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinomaHepatology, 2000